Repligen
RGEN
#2606
Rank
ยฃ5.03 B
Marketcap
ยฃ89.21
Share price
0.01%
Change (1 day)
-6.42%
Change (1 year)
Categories

Repligen (RGEN) - Total assets

Total assets on the balance sheet as of December 2025 : ยฃ2.19 Billion

According to Repligen 's latest financial reports the company's total assets are ยฃ2.19 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Repligen - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-12-31ยฃ2.19 B-2.86%
2024-12-31ยฃ2.25 B1.47%
2023-12-31ยฃ2.22 B6.2%
2022-12-31ยฃ2.09 B19.77%
2021-12-31ยฃ1.74 B25.15%
2020-12-31ยฃ1.39 B30.75%
2019-12-31ยฃ1.06 B74.97%
2018-12-31ยฃ0.61 B10.93%
2017-12-31ยฃ0.55 B134.96%
2016-12-31ยฃ0.23 B137.28%
2015-12-31ยฃ98.68 M19.75%
2014-12-31ยฃ82.4 M14.56%
2013-12-31ยฃ71.92 M19.84%
2012-12-31ยฃ60.02 M
2011-03-31ยฃ45.08 M-3.46%
2010-03-31ยฃ46.7 M-8.43%
2009-03-31ยฃ51 M48.83%
2008-03-31ยฃ34.26 M131.32%
2007-03-31ยฃ14.81 M-10.47%
2006-03-31ยฃ16.54 M12.93%
2005-03-31ยฃ14.65 M-8.14%
2004-03-31ยฃ15.95 M-6.15%
2003-03-31ยฃ16.99 M-16.79%
2002-03-31ยฃ20.42 M-10.09%
2001-03-31ยฃ22.71 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
ยฃ155.02 B 6,956.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
ยฃ82.17 B 3,640.82%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
ยฃ96.94 B 4,312.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ67.05 B 2,952.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
ยฃ66.01 M-96.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
ยฃ0.87 B-60.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ3.44 B 57.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
ยฃ1.87 B-14.48%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ5.65 B 157.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
ยฃ5.31 B 141.90%๐Ÿ‡บ๐Ÿ‡ธ USA